Accessibility Menu
 
Microbix Biosystems logo

Microbix Biosystems

(OTC) MBXBF

Current Price$0.18
Market Cap$25.17M
Since IPO (2012)-39%
5 Year-62%
1 Year-31%
1 Month+4%

Microbix Biosystems Financials at a Glance

Market Cap

$25.17M

Revenue (TTM)

$14.82M

Net Income (TTM)

$5.24M

EPS (TTM)

$-0.03

P/E Ratio

-6.12

Dividend

$0.00

Beta (Volatility)

0.11 (Low)

Price

$0.18

Volume

500

Open

$0.18

Previous Close

$0.18

Daily Range

$0.18 - $0.18

52-Week Range

$0.15 - $0.29

MBXBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Microbix Biosystems

Industry

Biotechnology

CEO

Cameron L. Groome

Headquarters

Mississauga, ON L4Z 1P3, CA

MBXBF Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

-33%

Net Income Margin

-39%

Return on Equity

-21%

Return on Capital

-16%

Return on Assets

-16%

Earnings Yield

-16.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.17M

Shares Outstanding

138.55M

Volume

500

Avg. Volume

6.42K

Financials (TTM)

Gross Profit

$9.87M

Operating Income

$1.58M

EBITDA

$203.49K

Operating Cash Flow

$80.40K

Capital Expenditure

$798.42K

Free Cash Flow

$878.82K

Cash & ST Invst.

$12.13M

Total Debt

$8.08M

Microbix Biosystems Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.39M

-36.4%

Gross Profit

$1.63M

-48.5%

Gross Margin

48.20%

N/A

Market Cap

$25.17M

N/A

Market Cap/Employee

$251.72K

N/A

Employees

100

N/A

Net Income

$1.43M

-7039.8%

EBITDA

$800.91K

-214.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$1.34M

-85.4%

Accounts Receivable

$3.27M

+30.1%

Inventory

$10.10M

+22.1%

Long Term Debt

$5.87M

+11.8%

Short Term Debt

$943.89K

+864.4%

Return on Assets

-16.18%

N/A

Return on Invested Capital

-15.80%

N/A

Free Cash Flow

$531.77K

-173.7%

Operating Cash Flow

$308.56K

-131.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PVCTProvectus Biopharmaceuticals, Inc.
$0.07-0.91%
RVXCFResverlogix Corp.
$0.07+0.00%
DTCFFDefence Therapeutics Inc.
$0.35+0.02%
FNCHFinch Therapeutics Group, Inc.
$7.45+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
AALAmerican Airlines Group
$13.85+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.26+0.04%
TET1 Energy Inc.
$8.08-0.07%

Questions About MBXBF

What is the current price of Microbix Biosystems?

Microbix Biosystems is trading at $0.18 per share.

What is the 52-week range for Microbix Biosystems?

Over the past 52 weeks, Microbix Biosystems has traded between $0.15 and $0.29.

How much debt does Microbix Biosystems have?

As of the most recent reporting period, Microbix Biosystems reported total debt of $4.87M.

How much cash does Microbix Biosystems have on hand?

Microbix Biosystems reported $5.83M in cash and cash equivalents in its most recent financial results.

What is Microbix Biosystems’s dividend yield?

Microbix Biosystems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.